Merck files for FDA approval of Keytruda in lung cancer
April 19, 2015 at 08:00 AM EDT
April 19 (Reuters) - Merck & Co Inc said on Sunday it has submitted an application to the U.S. Food and Drug Administration for its drug Keytruda as a treatment for advanced non-small cell lung cancer, the most common form of the disease.
